|
|
||||||||
Published online before print May 15, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
and interleukin-6
,
,
,
,
*Vaccine Research and Development Center, National Health Research Institutes, Miaoli, Taiwan, Republic of China;
Graduate Institute of Medical Biotechnology, Chang Gung University, Tao-Yuan, Taiwan, Republic of China;
Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, Republic of China; and
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China
@ To whom correspondence should be addressed. E-mail: chenhw{at}nhri.org.tw.
| Abstract |
|---|
Cross-talk between TGF-
and IL-6 has been shown to direct the differentiation of CD4+ cells into special IL-17-secreting cells, which are termed Th17 cells. In this study, we demonstrated that TGF-
and IL-6 could stimulate CD8+ cells to differentiate into noncytotoxic, IL-17-producing cells in MLC. These IL-17-producing CD8+ cells exhibit a unique granzyme B-IFN-
-IL-10- phenotype. The mRNA level of Th2/Tc2 transcription factors GATA3 and Th1/Tc1 transcription factors T-bet as well as its target Hlx is decreased in CD8+ cells from TGF-
- and IL-6-treated MLC. In addition, these CD8+ cells display a marked up-regulation of retinoic acid-related orphan receptor-
t, a key IL-17 transcription factor. These results demonstrate that the existence of an IL-17-producing CD8+ subset belongs to neither the Tc1 nor the Tc2 subset and can be categorized as a Tnc17 subset.
Key Words: IL-17 mixed lymphocyte culture cytotoxic T lymphocyte
This article has been cited by other articles:
![]() |
B. E. Burrell, K. Csencsits, G. Lu, S. Grabauskiene, and D. K. Bishop CD8+ Th17 Mediate Costimulation Blockade-Resistant Allograft Rejection in T-bet-Deficient Mice J. Immunol., September 15, 2008; 181(6): 3906 - 3914. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yi, D. Zhao, C.-L. Lin, C. Zhang, Y. Chen, I. Todorov, T. LeBon, F. Kandeel, S. Forman, and D. Zeng Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease Blood, September 1, 2008; 112(5): 2101 - 2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Nam, M. Terabe, M.-J. Kang, H. Chae, N. Voong, Y.-a. Yang, A. Laurence, A. Michalowska, M. Mamura, S. Lonning, et al. Transforming Growth Factor {beta} Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17 Cancer Res., May 15, 2008; 68(10): 3915 - 3923. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |